Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research is to learn acceptable dosages of paclitaxel, oxaliplatin,
and Avastin (bevacizumab) that can be given in combination to patients with advanced
peritoneal carcinomatosis. The safety of this drug combination will also be studied.